LAKE ZURICH, Ill. & BETHESDA, Md.--(EON: Enhanced Online News)--Every day in the United States alone, approximately 41,000 units of blood are needed to help treat patients — from accident and trauma victims to transplant recipients and those fighting cancer. Blood collectors are the crucial link between volunteer blood donors and the patients who count on these lifesaving therapies.
“Blood-collection professionals, through their technical expertise and customer service focus, play a critical role in providing a quality experience for blood donors”
Blood collection professionals will be recognized Sept. 8-14, 2013, in communities worldwide as part of the ninth annual Blood Collectors Week. During this week, 300 blood centers throughout 11 countries are expected to host celebrations, often with local government officials, to recognize their staff members and donors.
Blood Collectors Week was created and is sponsored by AABB, a not-for-profit association dedicated to advancing transfusion medicine and cellular therapies, and Fenwal Inc., a Fresenius Kabi Company specializing in transfusion technologies.
“Blood-collection professionals, through their technical expertise and customer service focus, play a critical role in providing a quality experience for blood donors,” said AABB Chief Executive Officer Miriam A. Markowitz. “Positive blood donation experiences result in committed donors and the establishment of a safe and adequate blood supply for patients in need. National Blood Collectors Week is a wonderful opportunity to thank these professionals for their contributions."
According to the 2011 National Blood Collection and Utilization Report, more than 13 million units of whole blood and red blood cells were transfused in the United States in 2011.
“We are proud to continue our long standing partnership with AABB in supporting Blood Collector’s Week,” said Dean Gregory, president, Medical Devices for Fresenius Kabi North America. “The role of blood collection professionals cannot be understated and should be recognized since they help save and improve lives every day in our communities. Blood Collectors Week is one way to say ‘thank you’ to them.”
People typically receive transfusions of red blood cells, platelets or plasma. Red blood cells are the most frequently needed blood component. Blood collectors serve an important role helping individuals select the best donation option based on local blood supply needs, their blood type and donor qualifications. To donate blood, one must be healthy, and meet age, weight and other donor requirements.
Eligible individuals are encouraged to honor blood professionals and the patients they serve by contacting their local blood collection facility to schedule an appointment to donate.
Those interested in learning more about blood donation and finding a local blood collection site should visit www.aabb.org. For more information about Blood Collectors Week, visit www.bloodcollectors.org or follow us on twitter @bloodcollectors and #bloodcollectorsweek.
AABB is an international, not-for-profit association representing individuals and institutions involved in the field of transfusion medicine and cellular therapies. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership consists of nearly 2,000 institutions and 8,000 individuals, including physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. Members are located in more than 80 countries. For more information, visit www.aabb.org.
About Fresenius Kabi
Fresenius Kabi (www.fresenius-kabi.com) is a leading global health care company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients inside and outside the hospital. Our products include intravenous specialty and generic pharmaceuticals, infusion therapies, clinical nutrition and related medical devices. Within transfusion medicine, we offer products for whole blood collection and processing, plasma collection and cell therapies. The company’s roots go back more than 100 years to the founding of Fresenius SE, in Bad Homburg, Germany, where the company is headquartered today.
In addition to Fenwal transfusion products in the United States, Fresenius Kabi also offers a broad portfolio of injectable and specialty pharmaceutical products under the APP brand (www.APPpharma.com). In 2012, Fresenius Kabi acquired Fenwal Inc. (www.fenwalinc.com), expanding the Fresenius Kabi offering to include Fenwal products for transfusion medicine. These include advanced medical technologies used in blood separation, collection, filtration, storage and transfusion.